EUCTR2019-001491-11-IT进行中（未招募）1 期
Phase IV study for efficacy and safety of Evolocumab added to Ezetimibe (Standard of Care) in high cardiovascular risk haemodialized statin intolerant patients with hypercholesterolemia. - EV01
IRCCS SAN RAFFAELE PISANA GESTITO DA SAN RAFFAELE ROMA SR0 个研究点目标入组 50 人开始时间: 2021年5月24日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Patients will be included in the study if all of the following criteria are met:
- •- Age = 18; both genders.
- •- High cardiovascular risk patients defined as: patients with established coronary heart disease (CHD), OR patients with CHD risk equivalents (ischemic stroke, peripheral artery disease, diabetes mellitus plus at least 2 additional risk factors);
- •- Statin-intolerant patients with not adequately controlled LDL-C levels (=70 mg/dL)
- •- Patients with uremia on periodic haemodialysis treatment.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 50
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 25
排除标准
- •- LDL-C <70 mg/dL
- •- Age < 18 years.
研究者
相似试验
招募中
4 期
A clinical trial to study the safety and efficacy of Pulmosil (Sildenafil Injection) for the treatment of hypertension.CTRI/2016/11/007424Sun Pharmaceutical Industries Limited
进行中（未招募）
1 期
Prospective Phase IV Clinical Trial on Effectiveness of Rebif Treatment of CIS and RMS Patients in Romania using Electronic Device RebiSmart™EUCTR2014-001290-14-ROMERCK ROMANIA SR
已完成
1 期
Evaluation of efficacy and safety of Ebola vaccine iEvac-Z in humaJPRN-jRCTs031190118Koga Michiko30
进行中（未招募）
1 期
Study comparing the efficacy and safety of Benzydamine hydrochloride 0,3% oromucosal spray and Benzydamine hydrochloride 3 mg lozenges in patients with acute sore throat.acute sore throatEUCTR2019-003257-29-HUAngelini S.p.A.363
进行中（未招募）
1 期
Study comparing the efficacy and safety of Benzydamine hydrochloride 0,3% oromucosal spray and Benzydamine hydrochloride 3 mg lozenges in patients with acute sore throat.EUCTR2019-003257-29-PLAngelini S.p.A.356